Akorn Стоимость предприятия
Что обозначает Стоимость предприятия в Akorn?
Стоимость предприятия Akorn, Inc. является $806.12M
Какое определение для Стоимость предприятия?
Стоимость предприятия является измерением общей рыночной стоимости компании. Она рассчитывается как рыночная капитализация с учётом долга, доли меньшинства и привилегированных акций за вычетом общей суммы денежных средств и их эквивалентов.
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Стоимость предприятия компаний в Health Care сектор на OTC по сравнению с Akorn
Что делает Akorn?
Akorn, Inc., a specialty pharmaceutical company, develops, manufactures, and markets generic and branded prescription pharmaceuticals, over-the-counter (OTC) consumer health products, and animal health pharmaceuticals in the United States and internationally. The company operates in two segments, Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment offers generic and branded prescription pharmaceuticals in various dosage forms, including sterile ophthalmics, injectables, and inhalants; and non-sterile oral liquids, topicals, nasal sprays, and otics. Its primary products include Akten, a topical ocular anesthetic gel; AzaSite, an antibiotic used to treat bacterial conjunctivitis; Cosopt, Cosopt PF, Betimol, and Zioptan, which are used in the treatment of glaucoma; and Xopenex inhalation solution used in the treatment or prevention of bronchospasm. The Consumer Health segment manufactures and markets OTC products for the treatment of dry eye under the TheraTears brand. It also markets other OTC consumer health products comprising Mag-Ox, a magnesium supplement; and the Diabetic Tussin line of cough and cold products. In addition, this segment offers a portfolio of animal health products, such as Anased and VetaKet veterinary sedatives; Tolazine and Yobine sedative reversing agents; and Butorphic, a pain reliever. Further, the company sells its products to wholesale distributors. Akorn, Inc. was founded in 1971 and is headquartered in Lake Forest, Illinois. On May 20, 2020, Akorn, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Компании с стоимость предприятия похож на Akorn
- Barrett Business Services имеет Стоимость предприятия из $804.90M
- Pipestone имеет Стоимость предприятия из $805.08M
- Saregama India имеет Стоимость предприятия из $805.08M
- Oasis Petroleum имеет Стоимость предприятия из $805.33M
- Princess Private Equity имеет Стоимость предприятия из $805.39M
- SII SA имеет Стоимость предприятия из $805.40M
- Akorn имеет Стоимость предприятия из $806.12M
- Seven West Media имеет Стоимость предприятия из $806.32M
- Surge имеет Стоимость предприятия из $806.62M
- Wesdome Gold Mines имеет Стоимость предприятия из $808.60M
- Shenzhen Investment Bay Area Development имеет Стоимость предприятия из $809.11M
- Brilliance China Automotive имеет Стоимость предприятия из $809.71M
- The McClatchy имеет Стоимость предприятия из $809.79M